Neoadjuvant semaglutide showed no benefit in weight loss, diabetes remission or safety in a cohort of patients who underwent ...

To prevent muscle loss, more physicians are emphasizing the importance of fat loss vs weight loss for patients taking GLP-1 ...

India faces a looming health crisis as obesity rates climb. The Good Bug introduces a pioneering Advanced Metabolic System, ...

In the third part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief ...

Conducted in partnership with Morning Consult, the study found that GLP-1 users are increasingly prioritizing high-protein, ...

The group had a bad week after turmoil at the FDA, continuing a long period of underperformance following the pandemic.

Dr. Michael Greger is famous for several books including “How Not to Die,” and for his website nutritionfacts.org. He ...

Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...

The rise of GLP-1 drugs like Ozempic are changing consumer food waste patterns both at home and in restaurant settings.

Dividend stocks have been a reliable cornerstone for those who want to anchor their portfolios when markets get shaky. These ...

Ozempic was once just another prescription drug in a commercial featuring athletic, happy people. Now, it’s everywhere, and ...

Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...